ArticleRSC advances2025

Design, eco-friendly synthesis, and molecular docking studies of isatin hybrids as promising therapeutic agents (anticancer, anticholinesterase inhibitor, α-glucosidase inhibitor, and anti-MRSA).

Israa A SeliemPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.